Clinical Trials in Denver

Showing 14621-14640 of 18,038 trials

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

NCT00124189

The purpose of this study is to determine the safety and maximum tolerated dose of GRN163L in treating patients with refractory or relapsed chronic lymphoproliferative disease.

Chronic Lymphoproliferative Diseases

Geron Corporation48 participantsStarted Jul 2005

Denver, Colorado, United States • Hackensack, New Jersey, United States • Buffalo, New York, United States +5 more locations

TERMINATEDPhase 2< 1 mile

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

NCT00272181

The purpose of this study is to determine the safety, effectiveness, and recommended dose of Proxinium in North American patients with Squamous Cell Head and Neck Cancer

Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more

Sesen Bio, Inc.15 participantsStarted Jan 2006

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +16 more locations

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Find Trials by Condition in Denver

Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)

Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children